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Abstract
Background: It has been suggested that adverse postoperative outcomes may have a negative impact
on longterm survival in patients with colorectal liver metastases.
Objectives: This study was conducted to evaluate the prognostic impact of postoperative complica-
tions in patients submitted to a potentially curative resection of colorectal liver metastases.
Methods: A retrospective analysis of outcomes in 199 patients submitted to hepatic resection with
curative intent for metastatic colorectal cancer during 1999–2008 was conducted.
Results: The overall complication rate was 38% (n = 75). Of all complications, 79% were minor (Grades
I or II). There were five deaths (3%). The median length of follow-up was 39 months. Rates of 5-year
overall and disease-free survival were 44% and 27%, respectively. Univariate analysis demonstrated that
an elevated preoperative level of carcinoembryonic antigen (CEA), intraoperative blood loss of >300 ml,
multiple metastases, large (≥35 mm) metastases and resection margins of <1 mm were associated with
poor overall and disease-free survival. In addition, male sex and synchronous metastases were associ-
ated with poor disease-free survival. Postoperative complications did not have an impact on either
survival measure. The multivariate model did not include complications as a predictive factor.
Conclusions: Postoperative complications were not found to influence overall or disease-free survival in
the present series. The number and size of liver metastases were confirmed as significant prognostic
factors.
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Introduction
Colorectal cancer (CRC) is the second leading cause of cancer-
related death in Australia, where approximately 4000 patients die
from this disease each year (age-standardized mortality is
approximately 18%).1 The liver is the most common site for meta-
static disease, and resection of isolated metastases prolongs sur-
vival and achieves cure in selected patients.2–4 Operative mortality
following liver resection is <5% in high-volume centres,5–8 but
postoperative morbidity rates remain as high as 56%.9–11
Numerous preoperative factors have been shown to predict
poor longterm outcomes following the resection of colorectal liver
metastases. These include an elevated serum carcinoembryonic
antigen (CEA) level, poor primary tumour differentiation and
primary tumour lymph node involvement.9 It has also been sug-
gested that postoperative complications following liver resection
may have a negative impact on longterm survival.11 However, the
mechanisms of this putative relationship are unclear.
The purpose of this study was to evaluate the prognostic impact
of postoperative complications, as defined by the Clavien–Dindo
system for grading complications,12 in patients submitted to resec-
tion for colorectal liver metastases. A secondary aim was to deter-
mine additional factors that might predict poor longterm survival
in these patients.
Materials and methods
A retrospective analysis of prospectively collected data was per-
formed. The study sample consisted of consecutive patients sub-
mitted to first-time liver resection with curative intent for
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colorectal liver metastases at Royal North Shore Hospital and
associated campuses during the study period of 1999–2008. Ethics
approval for the study was provided by the Human Research
Ethics Committee of the Northern Sydney Area Health Service.
Data collection and definitions
All data were collected prospectively and extracted from the
departmental liver database for retrospective analysis. Additional
information was obtained from the hospital or the consulting
surgeon’s records. A range of demographic, clinical, radiological,
pathological and follow-up variables were assessed.
Synchronous liver metastases were defined as those presenting
within 4 months of the primary CRC diagnosis; metachronous
liver metastases were defined as those identified at >4 months after
the primary CRC diagnosis.
Intraoperative data collected included the total duration of
inflow occlusion (Pringle manoeuvre), the estimated volume
of blood loss, and the transfusion of blood products. Liver resec-
tion nomenclature was documented as per the Brisbane terminol-
ogy.13 Minor liver resections were defined as those in which up to
two Couinaud liver segments were removed and major liver resec-
tions were defined as those in which three or more Couinaud liver
segments were removed.
All perioperative morbidity was recorded in a prospective
manner. All complications recorded were reviewed weekly at the
unit meeting. These complications were categorized using the
Clavien–Dindo system of classification.12 The highest grade com-
plication was recorded for each patient. Postoperative liver failure,
postoperative bleeding and postoperative bile leakage were docu-
mented using standard definitions as per the International Study
Group of Liver Surgery.14–16
Perioperative mortality referred to death during the same
admission (in-hospital) or within 90 days of surgery. For sur-
vival analyses, patients were divided into two groups consisting
of: (i) those patients requiring intervention (complications of
Clavien–Dindo Grade II or higher), and (ii) those patients who
either had no postoperative complications or had complications
that did not require intervention (Clavien–Dindo Grade I). Spe-
cifically, patients who died in the perioperative period (Clavien–
Dindo Grade V complication) were excluded from the survival
analyses because otherwise death would represent both a predic-
tor and an outcome measure in this group. Overall survival (OS)
was defined as the time from hepatic surgery to the date of death
(all-cause mortality). Disease-free survival (DFS) was defined as
the time from hepatic surgery to the date of either death or the
first evidence of recurrence (local, regional or metastatic).
Follow-up time was taken as the time from hepatic surgery to
the date of last follow-up. Follow-up and survival times were
recorded in months.
Histopathological findings in the primary CRC and the liver
metastases were obtained from hospital pathology reports. For the
primary cancer, these data included the location and differentia-
tion of the tumour, and lymph node status. For liver metastases,
these data included the size of the largest tumour, the number of
metastases and the tumour differentiation. Patients were stratified
according to liver resection margins for the purpose of analysis:
R2 represented a margin with macroscopic involvement; R1 rep-
resented a margin with microscopic involvement, and R0 repre-
sented a negative margin. Margins were measured as <1 mm,
1–10 mm and >10 mm.
Preoperative workup and operative technique
All patients underwent a baseline preoperative assessment that
included liver function tests, coagulation studies, serum CEA
levels and a fine-cut, multi-phase computed tomography (CT)
scan of the abdomen and thorax. From January 2004, a positron
emission tomography (PET) scan was also performed to exclude
extrahepatic disease. All patients were discussed at a multidisci-
plinary group meeting prior to liver resection. Operative
criteria included the likelihood of achieving an R0 resection
(microscopically clear margin) along with the preservation of
vascular inflow and outflow and an adequate post-resection liver
remnant volume. Patients with limited extrahepatic intra-
abdominal disease (e.g. portahepatis lymph node involvement or
isolated upper quadrant peritoneal disease) were not excluded
from resection. Liver transection was performed using the
Cavitron Ultrasonic Surgical Aspirator (CUSA) dissection device
(Integra LifeSciences Corp., Plainsboro, NJ, USA) under low
central venous pressure conditions with intermittent inflow
occlusion.
The follow-up regime included 6-monthly clinical evaluations,
assessment of serum tumour markers and annual CT scans of the
thorax and abdomen. Triple-phase contrast-enhanced magnetic
resonance imaging was performed if clinically indicated. Patients
were followed up annually indefinitely after the initial 5-year
follow-up.
Statistical analysis
Demographic descriptive statistics were reported using the mean
± standard deviation (SD) and median [interquartile range
(IQR)] depending on the distribution. Kaplan–Meier curves with
95% Greenwood bands were constructed for overall and disease-
free survival. Patients with Grade V complications (perioperative
patient death) were excluded from survival analyses.
Inferential univariate survival analysis was performed using the
log-rank test after the conversion of variables into categorical
variables. The cut-off value selected for these categorical variables
either represented a clinically relevant quantity or was used to
divide the groups into equal binary groups. Multivariate analysis
was performed by constructing Cox proportional hazards models
from potentially significant covariates identified in the univariate
analysis (P <0.2). The purposeful selection of covariates method
was used to select variables for the final model (i.e. stepwise
removal whereby covariates thought to be clinically significant
were retained if necessary). The final model was then assessed
for the validity of the proportional hazards assumption
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using Shoenfeld residuals and goodness-of-fit using Cox–Snell
residuals. Data management and statistical analyses were per-
formed using stata SE for Windows Version 11.2 (StataCorp LP,
College Station, TX, USA).
Results
Patient characteristics
During the study period of 1999–2008, 224 patients underwent
resection for colorectal liver metastases. Ten of these patients
(4%) underwent laparoscopy or laparotomy only because of
unsuspected intra- or extrahepatic disease. Fifteen patients
underwent a repeat liver resection during the study period (14
had one repeat resection and one had two repeat resections).
The remaining 199 patients underwent a first-time liver resec-
tion with curative intent. These patients are the subject of this
study.
The clinicopathological characteristics of the study group are
outlined in Table 1.
The majority of patients (71%) had a primary colon cancer and
63% (121/192) of the whole cohort had node-positive primary
tumours. Overall, 54% of patients had metachronous liver metas-
tases and half of these underwent liver surgery within 1 year of the
primary cancer resection. Nine patients (5%) submitted to a sim-
ultaneous hepatic and colorectal resection and four patients (2%)
underwent a liver resection before bowel surgery.
The overall complication rate was 38%. The majority of com-
plications were minor (Grades I and II). Major complications
(Grades III and IV) occurred in 11 patients (6%). Five patients
died during the postoperative period, giving an overall operative
mortality of 3%.
The median resection margin in all patients was 3 mm, which
reflects a parenchyma-sparing operative approach. An R0 resec-
tion was achieved in 159 (81%) patients and an R1 resection
occurred in the remaining patients (n = 38, 19%). There were no
R2 resections in this series.
Overall and disease-free survival
Median follow-up in these patients was 39 months (IQR: 19–64
months). Overall survival outcomes are documented in Fig. 1.
During the study period, the total number of deaths in the cohort
was 107 (54%) and the total time at risk amounted to 8827
months. Median survival was 48 months [95% confidence interval
(CI) 42–65] and 5-year OS was 44% (95% CI 37–52%).
Disease-free survival is shown in Fig. 2. The total number of
deaths or recurrences in the cohort was 143 (72%) and the total
time at risk amounted to 5707 months. Median DFS was 17
months (95% CI 12–23). Five-year DFS was 27% (95% CI
21–34%).
Univariate analysis
The univariate analysis for overall and disease-free survival is
presented in Table 2. Patients with a resection margin of <1 mm
had a worse outcome compared with those with a larger margin
(≥1 mm), with median survival of 39 months and 57 months,
respectively (P = 0.025). However, there was no statistically sig-
nificant difference between the R0 (<1 mm) and R1 groups
(median survival of 39 months in both groups; P = 0.679), which
may explain the lack of any statistically significant difference when
Table 1 Characteristics of 199 patientsa submitted to hepatic resec-
tion with curative intent for metastatic colorectal cancer
Variable
Demographic characteristics
Gender, male, n (%) 132 (66%)
Age, years, mean ± SD 63 ± 11
Temporal relationship, metachronous, n (%) 107 (54%)
Colon to hepatic surgery, months, median (IQR)
(n = 192)
12 (5–23)
CEA, μg/l, median (IQR) (n = 159) 8 (4–27)
Elevated CEA, n (%) 124 (78%)
Perioperative characteristics
Resection, major, n (%) 120 (60%)
Blood loss of >300 ml, n (%) (n = 195) 68 (35%)
Transfusion, n (%) (n = 189) 29 (15%)
Pringle duration >15 min, n (%) (n = 145) 112 (77%)
Operating time, min, median (IQR) (n = 190) 198 (150–266)
No complications, n (%) 123 (62%)
Clavien–Dindo grade, n (%) (n = 198)
Grade I 17 (9%)
Grade II 42 (21%)
Grade IIIa 5 (3%)
Grade IIIb 3 (2%)
Grade IVa 2 (1%)
Grade IVb 1 (1%)
Grade V 5 (3%)
Primary tumour characteristics
Location: colon, n (%) 141 (71%)
Location: rectum, n (%) 58 (29%)
Primary differentiation, poor, n (%) (n = 181) 27 (15%)
Lymph node status positive, n (%) (n = 192) 121 (63%)
Liver metastases characteristics
Margin, mm, median (IQR) (n = 197) 3 (1–10)
Margin R1 (0 mm), n (%) 38 (19%)
Margin <1 mm, n (%) 22 (11%)
Margin 1–10 mm, n (%) 94 (48%)
Margin >10 mm, n (%) 43 (22%)
Number of metastases, median (IQR) (n = 196) 2 (1–2)
Size of metastases, mm, median (IQR) (n = 195) 35 (24–57)
aNumbers available for analysis vary as shown.
SD, standard deviation; IQR, interquartile range; CEA, carcinoembryonic
antigen.
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R1 patients were compared with R0 (any margin) patients
(median survival: 39 months and 56 months, respectively;
P = 0.133).
Patients with postoperative complications requiring interven-
tion (Clavien–Dindo Grade II or higher) were compared with
those with Grade I or no complications in terms of overall
and disease-free survival. There were no statistically significant
differences for either outcome measure. This is confirmed
by the overlapping Kaplan–Meier curves demonstrated in
Figs 3 and 4.
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Figure 1 Kaplan–Meier curve for overall survival in 199 patients submitted to hepatic resection with curative intent for metastatic colorectal
cancer. 95% CI, 95% confidence interval
D
is
ea
se
−f
re
e 
su
rv
iva
l, 
%
0 12 24 36 48 60 72 84 96
Months from hepatic surgery
199 112 79 54 42 33 24 15 9
Number at risk
95% CI Survivor function
0
100
25
50
75
Figure 2 Kaplan–Meier curve for disease-free survival in 199 patients submitted to hepatic resection with curative intent for metastatic
colorectal cancer. 95% CI, 95% confidence interval
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Table 2 Summary of univariate analyses of overall survival (OS) and disease-free survival (DFS) performed by log-rank test in 199 patients
submitted to hepatic resection with curative intent for metastatic colorectal cancer
Variable n OS, months, median P-value DFS, months, median P-value
Sex 0.066 0.010
Female 67 83 25
Male 132 46 15
Age 0.089 0.188
<64 years 99 65 22
≥64 years 100 43 12
Temporal relationship 0.162 0.024
Synchronous 92 44 11
Metachronous 106 57 23
Colon to hepatic surgery 0.975 0.345
≤ 12 months 98 49 15
>12 months 93 48 21
Carcinoembryonic antigen 0.023 0.067
Normal 35 Not reached 29
Elevated 124 45 14
Resection 0.390 0.118
Minor 79 56 20
Major 119 48 16
Blood loss 0.026 0.012
≤ 300 ml 127 58 20
>300 ml 68 39 15
Transfusion 0.178 0.206
No 159 51 18
Yes 29 36 13
Pringle duration 0.303 0.161
≤ 15 min 33 60 22
>15 min 111 47 12
Operating time 0.647 0.238
<180 min 63 48 15
180–239 min 59 53 15
≥240 min 67 48 17
Complications, Clavien–Dindo 0.877 0.658
None or Grade I 140 51 17
Grades II–IV 53 49 18
Grade V, death 5 Excluded
Any complication (death excluded) 0.552 0.310
None 123 56 17
Any 70 45 18
Primary cancer 0.053 0.450
Colon 141 60 18
Rectum 57 44 15
Primary differentiation 0.503 0.645
Good/moderate 153 48 17
Poor 27 76 10
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Multivariate analysis
The final modes for OS and DFS are shown in Table 3. Large and
multiple metastases are important factors associated with poorer
OS and DFS.
Discussion
The development of a complication following major surgery may
prolong a patient’s hospital stay and is likely to increase overall
hospital costs. Complications often result in an extended intensive
care unit (ICU) admission, which has been shown to have a nega-
tive impact on longterm survival after both oncological and non-
oncological surgery.17 In the present study, the relationship
between postoperative morbidity and longterm outcome was
examined in 199 patients who underwent resection of colorectal
liver metastases. No relationship between the development of a
postoperative complication and longterm survival was found.
Major morbidity (defined as a complication of Clavien–
Dindo Grades III or IV) occurred in fewer than 6% of patients
Table 2 Continued
Variable n OS, months, median P-value DFS, months, median P-value
Lymph node status 0.105 0.172
Negative 71 56 23
Positive 120 45 15
Margin
R1 (0 mm) 38 39 11
R0 (<1 mm) 21 39 9
1–10 mm 94 56 17
>10 mm 43 60 45
<1 versus ≥1 0.025 <1 versus ≥1 0.001
R1 versus any R0 0.133 R1 versus any R0 0.004
Number of metastases 0.028 <0.001
Solitary 91 58 28
Multiple 104 39 11
Size of metastases 0.003 0.005
<35 mm 91 60 25
≥35 mm 103 36 12
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Figure 3 Kaplan–Meier survival curves comparing overall survival in patients with and without complications. C–D, Clavien–Dindo
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(n = 11/199). Five-year rates of OS and DFS in this series were 44%
and 27%, respectively. These are similar to those in the published
literature, although reported survival rates range widely from 9%
to 63% for OS and from 4% to 47% for DFS.18
Postoperative morbidity has long been thought to be a prog-
nostic factor in major surgery. In relation to hepatic resection for
colorectal metastases, Laurent et al. published an early landmark
study suggesting that postoperative complications adversely
affected both disease-free and overall survival.11 However, this
study was criticized for its failure to systematically define and
classify postoperative complications. Several years later, Schiesser
and colleagues used the Clavien–Dindo system12 to report mor-
bidity and found a negative relationship.19 However, this analysis
included postoperative deaths (Clavien–Dindo Grade V) in the
complication group, which caused a bias towards rejection of the
null hypothesis. In 2008, Vigano et al. reported a similar negative
relationship between postoperative morbidity and survival in 125
patients submitted to liver surgery for colorectal metastases.20
Again, this finding was questioned because there was no formal
definition or classification of complications and no reporting of
the effect on recurrence or DFS.
In contrast with the findings cited above, two large studies
failed to show an unequivocal relationship. Ito et al. found that the
presence of postoperative complications was not an independent
poor prognostic factor for either disease-specific or disease-free
survival in 1067 patients.5 Only a subgroup analysis of patients
with a low risk for recurrence (clinical risk scores of <3) demon-
strated an adverse relationship for both measures of survival.9
Confusingly, Farid et al., in a cohort of 705 patients, found a slight
survival disadvantage in terms of OS but not DFS. Interestingly,
there was a more definitive association with worse survival when
a secondary analysis of infective complications versus non-
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Figure 4 Kaplan–Meier survival curves comparing disease-free survival in patients with and without complications. C–D, Clavien–Dindo
Table 3 Final multivariate model for overall and disease-free survival in 199 patients submitted to hepatic resection with curative intent for
metastatic colorectal cancer
Variable HR 95% CI SE Z-value P-value
Overall survival
Rectal versus colon primary 1.42 0.94 2.14 0.30 1.68 0.093
Size ≥35 mm 2.04 1.36 3.05 0.42 3.45 0.001
Multiple (versus solitary) 1.82 1.22 2.71 0.37 2.94 0.003
Disease-free survival
Sex 1.60 1.10 2.31 0.30 2.49 0.013
Size ≥35 mm 1.97 1.40 2.79 0.35 3.84 <0.001
Multiple metastases (versus solitary) 2.08 1.47 2.95 0.37 4.13 <0.001
HR, hazard ratio; 95% CI, 95% confidence interval; SE, standard error.
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infective complications was undertaken.21 Unlike the study by
Schiesser et al.,19 both of the last two studies excluded patients
with Grade V complications (postoperative death).
More recently, in 2013 Mavros et al. examined the outcomes of
251 patients after liver resection and found a strong association
between complications and both overall and progression-free sur-
vival.22 Although postoperative deaths were excluded from the
analysis, the Kaplan–Meier chart suggested that at least two of 14
patients in the major complications group died within 30 days of
surgery, which may well have influenced the conclusion of the
study.
Evidence of an adverse effect of postoperative morbidity on
longterm survival has been found in other tumour types including
colonic, hepatocellular and oesophageal cancers.23–26 In an analysis
of 105 951 patients from the American College of Surgeons
National Surgical Quality Improvement Program (NSQIP)
database, Khuri et al. showed that postoperative complications
were associated with poor survival after eight different types of
major surgery, including non-cancer operations.27 This suggests
that the effect of postoperative morbidity on survival is likely to be
multifactorial, rather than related only to altered longterm cancer
behaviour. Other factors that might impact on medium- or
longterm pathophysiological stress, such as infection, cardiorespi-
ratory disease or even poor quality of life, may well be important.
Khuri et al. identified two distinct survival curves in patients with
and without postoperative complications with an inflection point
occurring between 27–180 days postoperatively.27 This suggests
that although the impact of complications seems to extend
beyond the immediate postoperative period, the duration of this
effect is, nonetheless, time-limited. This finding has implications
for interpretation of the literature and may explain the variable
results published to date. Specifically, the finding of an association
between complications and survival depends on: (i) the definition
of the postoperative mortality group and whether this group is
excluded from analysis; (ii) the relative importance of the physio-
logical insult compared with the cancer biology on survival, and
(iii) the degree of the physiological insult of the complication (and
therefore the timing of the inflection point). As a result, studies
that include early postoperative deaths tend to show an associa-
tion. Furthermore, the adverse effect of postoperative complica-
tions tends to be more prominent in subgroup analyses of
patients at low risk for recurrence or in those with infective
complications.5,21
Mechanistically, the effect of complications on survival may be
related to the immunomodulatory effect of the associated sys-
temic inflammatory response.27 Inflammation and inflammatory
cytokine release [especially of tumour necrosis factor-α (TNF-α),
interleukin-6 (IL-6) and IL-1] also play important roles in
carcinogenesis through their influence on tumour development
and immune response.28 A second putative pathway to
perioperative immunomodulation relates to perioperative blood
transfusion.29–32 Interestingly, of the six studies investigating the
effects on survival of postoperative complications, only that by
Farid et al. found blood transfusion to be a significant factor asso-
ciated with poor disease-free (but not overall) survival.5,11,19–22 Low
rates of blood transfusion in modern case series (often of <20%)
and different protocols for the transfusion of leuko-depleted
products or γ-irradiated packed cells may be important confound-
ing factors.
The present study also examined a range of other prognostic
factors and found that large or multiple liver metastases were
independent predictors of poor DFS and OS. Repeatedly, these
factors have been shown to be associated with worse longterm
survival and are often included in prognostic scoring systems.9,33–37
An important issue when analysing the impact of complica-
tions on longterm outcome is whether perioperative data were
collected prospectively or retrospectively. Minor complications
(Grades I or II) may be dismissed as part of the ‘normal’ postop-
erative course with retrospective analysis. A strength of the present
study was the use of prospectively collected and classified compli-
cation data, which limits the chance of under-reporting. The mor-
bidity and mortality rates after liver resection identified herein are
comparable with those reported in the literature.5,11,19,21 One draw-
back of the present study is the fact that the event rate for com-
plications was relatively small, and accordingly this analysis may
be underpowered to detect small differences in outcome.
Conclusions
In summary, the current study does not support the theory that
postoperative morbidity affects the longterm oncological
outcome of patients undergoing liver resection for colorectal
metastases. Unfortunately, evidence from the literature is incon-
sistent between different studies. In patients submitted to non-
oncological major surgery, there is evidence that being critically ill
postoperatively has a medium- to longterm impact on survival.
There are also plausible underlying mechanisms to explain this
effect. Although this relationship may also be true for patients
undergoing resection of colorectal liver metastases, the magnitude
of this effect may be limited.
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